Funding

OliX Pharmaceuticals

South Korea · Biotech · Healthtech

Develops RNAi therapeutics for various diseases

Visit olixpharma.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Strategic₩110BBOLD — Role not disclosedWeiss Asset Management LP — Role not disclosed

Investors

BOLDStrategicWeiss Asset Management LPStrategic

Coverage

Jun 4, 2026OliX Pharmaceuticals · Strategic

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesolixpharma.com ↗